Acquisition / mergerNotableFiled on BSE ·

IKS Health announces agreement to acquire TruBridge to enhance rural healthcare

Inventurus Knowledge Solutions · IT - Services

Arthneeti Research DeskPublished 1 min read

Key highlights

  • IKS Health to acquire TruBridge for $26.25 per share in cash, transaction expected Q3 2026
  • Acquisition approved by boards of IKS Health, IKS, and TruBridge; subject to customary closing conditions
  • IKS to finance acquisition mainly through new debt including term loan underwritten by Citibank, JPMorganChase, Deutsche Bank

Why it's rated notable: The filing states a per-share cash price of $26.25 but no total deal value, and closing remains subject to shareholder approval, the HSR waiting period and debt financing, so the event is not binding and is kept at medium.

Original filing

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Inventurus Knowledge Solutions

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.